Graft-vs-Host Disease in a Liver Transplant Patient With COVID-19 Infection.
ACG Case Rep J
; 10(1): e00971, 2023 Jan.
Article
in English
| MEDLINE | ID: covidwho-2242202
ABSTRACT
Graft-vs-host disease (GVHD) after liver transplant is a rare complication with high mortality outcomes. Because of the rarity of occurrence, there is no standardized consensus for treatment. Early recognition of symptoms and a multidisciplinary approach with input from transplant hepatology and hematology is important to determine a treatment plan and improve outcomes. We present a unique case of a 49-year-old woman who developed GVHD during a coronavirus disease 2019 (COVID-19) infection 3 months after receiving a liver transplant. More data are needed to determine whether COVID-19 infection itself correlates with a risk of developing GVHD.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Type of study:
Case report
/
Prognostic study
Language:
English
Journal:
ACG Case Rep J
Year:
2023
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS